{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:29:36Z","timestamp":1793759376605,"version":"4.6.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/carcin\/bgi049","type":"journal-article","created":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T01:13:27Z","timestamp":1108689207000},"page":"1044-1054","source":"Crossref","is-referenced-by-count":121,"title":["22-Oxa-1\u03b1,25-dihydroxyvitamin D 3 inhibits metastasis and angiogenesis in lung cancer"],"prefix":"10.1093","volume":"26","author":[{"given":"Kimie","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Kubodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,2,17]]},"reference":[{"key":"key\n\t\t\t\t20171011184027_B1","unstructured":"Ginsberg,R.J., Vokes,E.E. and Raben,A. ( 1997 ) Cancer of the lung. In Devita,V.T. and Helman,S.Jr (eds) Cancer: Principles and Practice of Oncology , 5th edn. Lippincott-Raven, New York, Vol. 1, pp. 849\u2013949."},{"key":"key\n\t\t\t\t20171011184027_B2","doi-asserted-by":"crossref","unstructured":"Young,M.R.I., Ihm,J., Lozano,Y., Wright,M.A. and Prechel,M.M. ( 1995 ) Treating tumor-bearing mice with vitamin D 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol. Immunother. , 41 , 37 \u201345.","DOI":"10.1007\/BF01788958"},{"key":"key\n\t\t\t\t20171011184027_B3","doi-asserted-by":"crossref","unstructured":"Young,M.R. and Lozano,Y. ( 1997 ) Inhibition of tumor invasiveness by 1\u03b1,25-dihydroxyvitamin D 3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin. Exp. Metastasis , 15 , 102 \u2013110.","DOI":"10.1023\/A:1018492525027"},{"key":"key\n\t\t\t\t20171011184027_B4","unstructured":"Eisman,J.A., Barkla,D.H. and Tutton,P.J.M. ( 1987 ) Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D 3 . Cancer Res. , 47 , 21 \u201325."},{"key":"key\n\t\t\t\t20171011184027_B5","unstructured":"Lokeshwar,B.L., Schwartz,G.G., Selzer,M.G., Burnstein,K.L., Zhuang,S.H., Block,N.L. and Binderup,L. ( 1999 ) Inhibition of prostate cancer metastasis in vivo : a comparison of 1,25\u2013dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol. Biomarkers Prev. , 8 , 241 \u2013248."},{"key":"key\n\t\t\t\t20171011184027_B6","doi-asserted-by":"crossref","unstructured":"Cross,H.S., Kallay,E., Farhan,H., Weiland,T. and Manhardt,T. ( 2003 ) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res. , 164 , 413 \u2013425.","DOI":"10.1007\/978-3-642-55580-0_30"},{"key":"key\n\t\t\t\t20171011184027_B7","doi-asserted-by":"crossref","unstructured":"Mantell,D.J., Owens,P.E., Bundred,N.J., Mawer,E.B. and Canfield,A.E. ( 2000 ) 1\u03b1,25-Dihydroxyvitamin D 3 inhibits angiogenesis in vitro and in vivo . Circ. Res. , 87 , 214 \u2013220.","DOI":"10.1161\/01.RES.87.3.214"},{"key":"key\n\t\t\t\t20171011184027_B8","doi-asserted-by":"crossref","unstructured":"Abe,J., Morikawa,M., Miyamoto,K., Kaiho,S., Fukushima,M., Miyaura,C., Abe,E., Suda,T. and Nishii,Y. ( 1987 ) Synthetic analogues of vitamin D 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett. , 226 , 58 \u201362.","DOI":"10.1016\/0014-5793(87)80550-1"},{"key":"key\n\t\t\t\t20171011184027_B9","doi-asserted-by":"crossref","unstructured":"Abe,J., Nakano,T., Nishii,Y., Matsumoto,T., Ogata,E. and Ikeda,K. ( 1991 ) A novel vitamin D 3 analog, 22-oxa-1,25-dihydroxyvitamin D 3 , inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology , 129 , 832 \u2013837.","DOI":"10.1210\/endo-129-2-832"},{"key":"key\n\t\t\t\t20171011184027_B10","doi-asserted-by":"crossref","unstructured":"Kobayashi,T., Tsugawa,N., Okano,T., Masuda,S., Takeuchi,A., Kubodera,N. and Nishii,Y. ( 1994 ) The binding properties, with blood proteins, and tissue distribution of 22-oxa-1\u03b1,25-dihydroxyvitamin D 3 , a noncalcemic analogue of 1\u03b1,25-dihydroxyvitamin D 3 , in rats. J. Biochem. , 115 , 373 \u2013380.","DOI":"10.1093\/oxfordjournals.jbchem.a124346"},{"key":"key\n\t\t\t\t20171011184027_B11","doi-asserted-by":"crossref","unstructured":"Oikawa,T., Yoshida,Y., Shimamura,M., Ashino-Fuse,H., Iwaguchi,T. and Tominaga,T. ( 1991 ) Antitumor effect of 22-oxa-1\u03b1,25-dihydroxyvitamin D 3 , a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Anti Cancer Drugs , 2 , 475 \u2013480.","DOI":"10.1097\/00001813-199110000-00007"},{"key":"key\n\t\t\t\t20171011184027_B12","unstructured":"Rashidi,B., Yang,M., Jiang,P., Baranov,E., An,Z., Wang,X., Moossa,A.R. and Hoffman,R.M. ( 2000 ) A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin. Exp. Res. , 18 , 57 \u201360."},{"key":"key\n\t\t\t\t20171011184027_B13","doi-asserted-by":"crossref","unstructured":"Nakagawa,K., Kawaura,A., Kato,S., Takeda,E. and Okano,T. ( 2005 ) 1\u03b1,25-Dihydroxyvitamin D 3 is a preventive factor in the metastasis of lung cancer. Carcinogenesis , 26 , 429 \u2013440.","DOI":"10.1093\/carcin\/bgh332"},{"key":"key\n\t\t\t\t20171011184027_B14","doi-asserted-by":"crossref","unstructured":"Hovey,R.C., Goldhar,A.S., Baffi,J. and Vonderhaar,B.K. ( 2001 ) Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cell during mouse mammary gland development. Mol. Endocrinol. , 15 , 819 \u2013831.","DOI":"10.1210\/mend.15.5.0635"},{"key":"key\n\t\t\t\t20171011184027_B15","unstructured":"Koli,K. and Keski-Oja,J. ( 2000 ) 1\u03b1,25-Dihydroxyvitamin D 3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. , 11 , 221 \u2013229."},{"key":"key\n\t\t\t\t20171011184027_B16","unstructured":"Sakamoto,N., Tanaka,N.G., Tohgo,A. and Ogawa,H. ( 1986 ) Heparin plus cortisone acetate inhibit tumor growth by blocking endothelial cell proliferation. Cancer J. , 1 , 55 \u201358."},{"key":"key\n\t\t\t\t20171011184027_B17","doi-asserted-by":"crossref","unstructured":"Kragh,M., Hjarnaa,P-N.V., Bramm,E., Kristjansen,P.E.G., Rygaard,J. and Binderup,L. ( 2003 ) In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. Int. J. Oncol. , 22 , 305 \u2013311.","DOI":"10.3892\/ijo.22.2.305"},{"key":"key\n\t\t\t\t20171011184027_B18","doi-asserted-by":"crossref","unstructured":"Yoshizawa,T., Handa,Y., Uematsu,Y., Takeda,S., Sekine,K., Yoshihara,Y., Kawakami,T., Arioka,K., Sato,H., Uchiyama,Y., Masushige,S., Fukamizu,A., Matsumoto,T. and Kato,S. ( 1997 ) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. , 16 , 391 \u2013396.","DOI":"10.1038\/ng0897-391"},{"key":"key\n\t\t\t\t20171011184027_B19","doi-asserted-by":"crossref","unstructured":"Ferrara,N. ( 2001 ) Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. , 280 , C1358 \u20131366.","DOI":"10.1152\/ajpcell.2001.280.6.C1358"},{"key":"key\n\t\t\t\t20171011184027_B20","doi-asserted-by":"crossref","unstructured":"Burtis,W.J., Brady,T.G., Orloff,J.J., Ersbak,J.B., Warrell,R.P., Olson,B.R., Wu,T.L., Mitnick,M.E., Broadus,A.E. and Stewart,A.F. ( 1990 ) Immunochemical characterization of circulating parathyroid hormone-related protein in patients with hormonal hypercalcemia of cancer. N. Engl. J. Med. , 322 , 1106 \u20131112.","DOI":"10.1056\/NEJM199004193221603"},{"key":"key\n\t\t\t\t20171011184027_B21","doi-asserted-by":"crossref","unstructured":"Bendre,M., Gaddy,D., Nicholas,R.W. and Suva,L.J. ( 2003 ) Breast cancer metastasis to bone: it is not all about PTHrP. Clin. Orthop. , 415 (Suppl), S39 \u2013S45.","DOI":"10.1097\/01.blo.0000093844.72468.f4"},{"key":"key\n\t\t\t\t20171011184027_B22","doi-asserted-by":"crossref","unstructured":"Maeda,Y., Yamato,H., Hirai,T., Kobori,N., Fujii,T., Kobayashi,Y., Saitoh,K., Inoguchi,E., Hakozaki,M. and Iijima,H. ( 1988 ) Antitumor and other effects of 24R,25\u2013dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice. Oncology , 45 , 202 \u2013205.","DOI":"10.1159\/000226562"},{"key":"key\n\t\t\t\t20171011184027_B23","doi-asserted-by":"crossref","unstructured":"Coven,V. and Kburi,F.R. ( 2003 ) Progress in lung cancer chemoprevention. Cancer Control , 10 , 315 \u2013324.","DOI":"10.1177\/107327480301000406"},{"key":"key\n\t\t\t\t20171011184027_B24","doi-asserted-by":"crossref","unstructured":"James,S.Y., MacKay,A.G. and Colston,K.W. ( 1996 ) Effects of 1,25-Dihydroxyvitamin D 3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol. , 58 , 395 \u2013401.","DOI":"10.1016\/0960-0760(96)00048-9"},{"key":"key\n\t\t\t\t20171011184027_B25","doi-asserted-by":"crossref","unstructured":"James,S.Y., Mercer,E., Brady,L. and Colston,K. ( 1998 ) EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro . Br. J. Pharmacol. , 125 , 953 \u2013962.","DOI":"10.1038\/sj.bjp.0702103"},{"key":"key\n\t\t\t\t20171011184027_B26","doi-asserted-by":"crossref","unstructured":"Nakagawa,K., Kurobe,M., Konno,K., Fujishima,T., Takayama,H. and Okano,T. ( 2000 ) Structure-specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60) cells by A-ring diastereomers of 2-methyl-1\u03b1,25-dihydroxyvitamin D 3 and its 20-epimer. Biochem. Pharmacol. , 60 , 1937 \u20131947.","DOI":"10.1016\/S0006-2952(00)00486-X"},{"key":"key\n\t\t\t\t20171011184027_B27","doi-asserted-by":"crossref","unstructured":"Nakagawa,K., Sowa,Y., Kurobe,M., Ozono,K., Siu-Caldera,M.L., Reddy,G.S., Uskokovic,M.R. and Okano,T. ( 2001 ) Differential activities of 1\u03b1,25-dihydroxy-16-ene-vitamin D 3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids , 66 , 327 \u2013337.","DOI":"10.1016\/S0039-128X(00)00142-2"},{"key":"key\n\t\t\t\t20171011184027_B28","doi-asserted-by":"crossref","unstructured":"Mehtal,R.G. and Mehta,R.R. ( 2002 ) Vitamin D and cancer. J. Nutr. Biochem. , 13 , 252 \u2013264.","DOI":"10.1016\/S0955-2863(02)00183-3"},{"key":"key\n\t\t\t\t20171011184027_B29","unstructured":"Abe-Hashimoto,J., Kikuchi,T., Matsumoto,T., Nishii,Y., Ogata,E. and Ikeda,K. ( 1993 ) Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res. , 53 , 2534 \u20132537."},{"key":"key\n\t\t\t\t20171011184027_B30","doi-asserted-by":"crossref","unstructured":"Barroga,E.F., Kadosawa,T., Okumura,M. and Fujinaga,T. ( 2000 ) Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo . Res. Vet. Sci. , 68 , 79 \u201387.","DOI":"10.1053\/rvsc.1999.0360"},{"key":"key\n\t\t\t\t20171011184027_B31","doi-asserted-by":"crossref","unstructured":"Hansen,C.M, Binderup,L., Hamberg,K., and Carlberg,C. Vitamin D and cancer: ( 2001 ) Effects of 1,25(OH) 2 D 3 and its analogs on growth control and tumorigenesis. Front. Biosci. , 6 , 820 \u2013848.","DOI":"10.2741\/A645"},{"key":"key\n\t\t\t\t20171011184027_B32","unstructured":"Wang,Q.M., Jones,J.B. and Studzinski,G.P. ( 1996 ) Cyclin-dependet kinase inhibitor p27 as a mediator of the G 1 \u2013S phase block induced by 1\u03b1,25-dihydroxyvitamin D 3 in HL-60 cells. Cancer Res. , 56 , 264 \u2013267."},{"key":"key\n\t\t\t\t20171011184027_B33","doi-asserted-by":"crossref","unstructured":"Munker,R., Kobayashi,T., Elstner,E., Norman,A.W., Uskokovic,M. and Zhang,W. ( 1996 ) A new series of vitamin D analogs in highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood , 88 , 2201 \u20132209.","DOI":"10.1182\/blood.V88.6.2201.bloodjournal8862201"},{"key":"key\n\t\t\t\t20171011184027_B34","doi-asserted-by":"crossref","unstructured":"Kumagai,T, O'Kelly,J., Said,J.W. and Koeffler,P. ( 2003 ) Vitamin D 2 analog 19-nor-1,25-dihydroxyvitamin D 2 : antitumor activity against leukemia, myeloma, and colon cancer cells. J. Natl Cancer Inst. , 95 , 896 \u2013905.","DOI":"10.1093\/jnci\/95.12.896"},{"key":"key\n\t\t\t\t20171011184027_B35","unstructured":"Schwartz,G.G., Wang,M.H., Zang,M., Singh,R.K. and Siegal,G.P. ( 1997 ) 1\u03b1,25-Dihydroxyvitamin D 3 (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomark. Prev. , 6 , 727 \u2013732."},{"key":"key\n\t\t\t\t20171011184027_B36","doi-asserted-by":"crossref","unstructured":"Lacraz,S., Dayer,J.M., Nicod,L. and Welgus,H.G. ( 1994 ) 1,25-Dihydroxyvitamin D 3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes. J. Biol. Chem. , 269 , 6485 \u20136490.","DOI":"10.1016\/S0021-9258(17)37397-0"},{"key":"key\n\t\t\t\t20171011184027_B37","doi-asserted-by":"crossref","unstructured":"Bian,J. and Sun,Y. ( 1997 ) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. , 17 , 6330 \u20136338.","DOI":"10.1128\/MCB.17.11.6330"},{"key":"key\n\t\t\t\t20171011184027_B38","doi-asserted-by":"crossref","unstructured":"Sato,H., Kita,M. and Seiki,M. ( 1993 ) v-Src activates the expression of 92-kDa Type IV collagenase gene through the AP-1 site and the GT box homologous to retinobrastoma control elements. J. Biol. Chem. , 268 , 23460 \u201323468.","DOI":"10.1016\/S0021-9258(19)49485-4"},{"key":"key\n\t\t\t\t20171011184027_B39","doi-asserted-by":"crossref","unstructured":"Hisatake,J., O'Kelly,J., Uskokovic,M.R., Tomoyasu,S. and Koeffler,H.P. ( 2001 ) Novel vitamin D 3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D 3 , that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood , 97 , 2427 \u20132433.","DOI":"10.1182\/blood.V97.8.2427"},{"key":"key\n\t\t\t\t20171011184027_B40","doi-asserted-by":"crossref","unstructured":"Iseki,K., Tatsuta,M., Uehara,H., Yano,H., Sakai,N. and Ishiguro,S. ( 1999 ) Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D 3 and 1,25-dihydroxyvitamin D 3 of colon carcinogenesis induced by azoxymethane in Wister rats. Int. J. Cancer , 81 , 730 \u2013733.","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20171011184027_B41","doi-asserted-by":"crossref","unstructured":"Schlaeppi,J.M., Gutzwiller,S., Finkenzeller,G. and Fournier,B. ( 1997 ) 1,25-Dihydroxyvitamin D 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res. , 23 , 213 \u2013229.","DOI":"10.3109\/07435809709031855"},{"key":"key\n\t\t\t\t20171011184027_B42","doi-asserted-by":"crossref","unstructured":"Lin,R., Amizuka,N., Sasaki,T., Aarts,M.M., Ozawa,H., Goltzman,D., Henderson,J.E. and White,J.H. ( 2002 ) 1Alpha,25-dihydroxyvitamin D 3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J. Bone Miner. Res. , 17 , 1604 \u20131612.","DOI":"10.1359\/jbmr.2002.17.9.1604"},{"key":"key\n\t\t\t\t20171011184027_B43","doi-asserted-by":"crossref","unstructured":"Falzon,M. and Zong,J. ( 1998 ) The noncalcemic vitamin D analogs EB1089 and 22-oxacalcitriol suppress serum-induced parathyroid hormone-related peptide gene expression in a lung cancer cell line. Endocrinology , 139 , 1046 \u20131053.","DOI":"10.1210\/endo.139.3.5774"},{"key":"key\n\t\t\t\t20171011184027_B44","doi-asserted-by":"crossref","unstructured":"Falzon,M. ( 1996 ) DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D 3 -mediated transcriptional repression. Mol. Endocrinol. , 10 , 672 \u2013681.","DOI":"10.1210\/mend.10.6.8776727"},{"key":"key\n\t\t\t\t20171011184027_B45","doi-asserted-by":"crossref","unstructured":"Tovar Sepulveda,V.A. and Falzon,M. ( 2003 ) Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE. Mol. Cell. Endocrinol. , 204 , 51 \u201364.","DOI":"10.1016\/S0303-7207(03)00148-5"},{"key":"key\n\t\t\t\t20171011184027_B46","doi-asserted-by":"crossref","unstructured":"Ionescu,A.M., Schwarz,E.M., Vinson,C., Puzas,J.E., Rosier,R., Reynolds,P.R. and O'Keefe,R.J. ( 2001 ) PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J. Biol. Chem. , 276 , 11639 \u201311647.","DOI":"10.1074\/jbc.M006564200"},{"key":"key\n\t\t\t\t20171011184027_B47","doi-asserted-by":"crossref","unstructured":"Mohamed,M.I., Beckman,M.J., Meehan,J. and DeLuca,H.F. ( 1996 ) Effect of 1,25-dihydroxyvitamin D 3 on mouse thymus: role of extracellular calcium. Biochem. Biophys. Acta , 1289 , 275 \u2013283.","DOI":"10.1016\/0304-4165(95)00167-0"},{"key":"key\n\t\t\t\t20171011184027_B48","doi-asserted-by":"crossref","unstructured":"Cantorna,M.T., Humpal-Winter,J. and DeLuca,H.F. ( 1999 ) Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J. Nutr. , 129 , 1966 \u20131971.","DOI":"10.1093\/jn\/129.11.1966"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/26\/6\/1044\/7089024\/bgi049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T05:49:43Z","timestamp":1625464183000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/26\/6\/1044\/2390850\/22Oxa1\u03b125dihydroxyvitamin-D-3-inhibits-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,17]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,2,17]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi049","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,2,17]]}}}